Novo Nordisk establishes new factory in Denmark
Av The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release.
– We are proud to build on our legacy in Denmark and look forward to embarking on this journey in Odense, a well-connected city with a dynamic community and skilled workforce, says Henrik Wulff, Executive Vice President for Product Supply, Quality & IT at Novo Nordisk.
The investment is expected to create approximately 400 new jobs.
In addition, Novo Nordisk has received approval for its acquisition of the contract manufacturer Catalent for $11.7 billion. The acquisition means Novo Nordisk will take over Catalent's three pharmaceutical production facilities located in Italy, Belgium, and the USA.
Artikeln är en del av vårt tema om News in English.